Ilumina Corporation

Illumina provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services.

Funding Status: IPO
Industry: Pharma
Technology: Biomarker Development
Number Of Exists: 2
Headquarters: San Diego, California, United States
Investor Type: Accelerator
Employee Number: 5001-10000
Investment Stage: Early Stage Venture, Late Stage Venture
Founded Date: 1998